课题基金 / 基金详情

项目摘要

项目成果

David W Li的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent studies have shown that a-crystallins are strong anti-apoptotic regulators, preventing apoptosis induced by a large number of stress factors. However, the molecular mechanisms by which a-crystallins suppress apoptosis remain largely unknown until our recent studies in which we have demonstrated that a-crystallins are capable of abrogating the apoptotic process in several different mechanisms. First, by interacting with procaspase-3 and the partially processed intermediate, a B - crystallin can repress activation of procaspase-3 and thus prevent stress-induced apoptosis. Second, through interactions with Bax and Bcl-Xs, aA- and aB-crystallins can sequester their translocation into mitochondria to block stress-induced apoptosis. Finally, by repressing the RAS/RAF/MEK/ERK signaling pathway, aB-crystallin is able to intervene UVA- and other stress-induced apoptosis. In contrast, aA-crystallin is found capable of promoting activation of the Akt surviving pathway to counteract UVA- and other stress-induced apoptosis. Our observations have been confirmed by recent studies from numerous laboratories. Major findings from these laboratories are 1) alphaBcrystallin interacts with caspase-3 and its precursors in cardiomyocytes and neuroglial cells besides in lens epithelial cells; 2) knockout of both a-crystallins leads to upregulation of caspase-3 and caspase-6 in the fiber cell zone of the ocular lens where secondary lens fiber cell disintegration occurs, causing apoptosis and cataract; 3). The total and phospho-ERKl 12 and p38 are much enhanced in the astrocytes of the aB(-I-) mice than in those from normal mice with the same genetic background; Finally, Member of the heat shock protein family, hsp60, directly interacts with Bax; Based on these results together, we hypothesize that a-crystallins can modulate multiple steps and signaling pathways, which are fundamental to both lens differentiation and lens pathology.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2174/15665240113139990061
发表时间: 2013-08
期刊: Current molecular medicine
影响因子: 2.5
作者: [W-b Liu;X-H Hu;X-W Zhang;M. Deng;L. Nie;S. Hui;W. Duan;M. Tao;C. Zhang;J. Liu;W-F Hu;Z-X Huang;L. Li;M. Yi;T-T Li-T;L. Wang;Y. Liu;S. Liu;D. W. Li]
通讯作者: W-b Liu;X-H Hu;X-W Zhang;M. Deng;L. Nie;S. Hui;W. Duan;M. Tao;C. Zhang;J. Liu;W-F Hu;Z-X Huang;L. Li;M. Yi;T-T Li-T;L. Wang;Y. Liu;S. Liu;D. W. Li
Towards better understanding on psychiatric disorder, ocular diseases, heart disease and cancer.
更好地了解精神疾病、眼部疾病、心脏病和癌症。
DOI: 10.2174/1566524011313060001
发表时间: 2013
期刊: Current molecular medicine
影响因子: 2.5
作者: [Li,DavidWan-Cheng]
通讯作者: Li,DavidWan-Cheng
DOI: 10.2174/1566524011307010001
发表时间: 2012-12
期刊: Current Molecular Medicine
影响因子: 2.5
作者: [David Wan-Cheng]
通讯作者: David Wan-Cheng
DOI: 10.2174/1566524011313090067
发表时间: 2013-06
期刊: Current molecular medicine
影响因子: 2.5
作者: [L. Li;L. Wang;T-T Li-T;X. Li;X.–Q. Huang;X-W Chen;Z. Li;X. Lv;F-Y Liu;Z-W Luo;M. Liu;X-H Hu;W-F Hu;Z-X Huang;M. Yi;S. Liu;Y.-Z. Liu;D. W. Li]
通讯作者: L. Li;L. Wang;T-T Li-T;X. Li;X.–Q. Huang;X-W Chen;Z. Li;X. Lv;F-Y Liu;Z-W Luo;M. Liu;X-H Hu;W-F Hu;Z-X Huang;M. Yi;S. Liu;Y.-Z. Liu;D. W. Li
Regulation of Apoptotic Signaling Pathways by Alpha-Crystallins in the Ocular Len
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
  • 批准号:
    6917472
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2005
  • 负责人:
    David W Li
  • 依托单位:
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: